Tata India Pharma & Healthcare Fund - Direct - Growth

Equity Scheme by Tata Asset Management Limited

3Y Returns (CAGR)
20.15%
Expense Ratio
1.02%

as of 01/08/2026

AUM
₹439.04 Cr

Qtr End: Jun 26

NAV
₹39.689

as of 02/09/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M8.42%38.16%8.37%
6M13.76%29.42%12.54%
1Y11.06%11.06%11.63%
3Y73.45%20.15%13.36%
5Y103.18%15.23%13.08%
Scheme Details
Launch Date
04/12/2015
Fund Age
10.7 years
Minimum Investment
₹5,000
Fund House
Tata Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions